Your session is about to expire
Nitrofurantoin vs Bactrim
Introduction
For patients suffering from urinary tract infections (UTIs), certain antibiotics that inhibit the growth of bacteria can help in managing symptoms and eliminating the infection. Nitrofurantoin and Bactrim are two such drugs that are commonly prescribed for UTIs. They each target different aspects of bacterial function, but both have bactericidal effects on a wide range of pathogens causing UTIs. Nitrofurantoin is an antibiotic that damages bacterial DNA, thereby inhibiting its ability to proliferate within the urinary tract. Bactrim, on the other hand, is a combination drug consisting of sulfamethoxazole and trimethoprim which disrupts folate synthesis - a crucial step in bacterial cell reproduction.
Nitrofurantoin vs Bactrim Side By Side
| Attribute | Macrobid | Bactrim |
|---|---|---|
| Brand Name | Macrobid | Bactrim |
| Contraindications | Kidney disease | Significant liver disease, previous allergic reactions to sulfa medications |
| Cost | About $0.60/day for generic | As low as about $0.25 up to more than a dollar per day for generic |
| Generic Name | Nitrofurantoin | Sulfamethoxazole/Trimethoprim |
| Most Serious Side Effect | Signs of lung problems, changes in the amount or color of your urine, unusual fatigue or weakness, numbness or tingling in your hands and feet, symptoms of liver problems | Allergic reactions, severe skin reactions, severe intestinal condition due to C. difficile, severe liver problems, unusual bleeding/bruising, severe kidney problems |
| Severe Drug Interactions | Probenecid and sulfinpyrazone | Dofetilide and methenamine |
| Typical Dose | 50-100 mg four times daily | 160/800 mg (sulfamethoxazole/trimethoprim) twice daily |
What is Nitrofurantoin?
Nitrofurantoin (commonly known by its brand name Macrobid) is a unique type of antibiotic, developed specifically to target urinary tract infections (UTIs). This specialized focus was a significant advancement upon the use of broader-spectrum antibiotics like Bactrim. Nitrofurantoin was first approved by the FDA in 1953. It works by damaging bacterial DNA, effectively inhibiting growth and multiplication of bacteria within the urinary tract. It's prescribed primarily for treating acute cystitis or preventing recurrent UTIs.
On the other hand, Bactrim is a combination drug containing sulfamethoxazole and trimethoprim; it acts on different stages of bacterial metabolic processes which makes it highly effective against a variety of infections - not just those confined to the urinary tract.
While Nitrofurantoin is more concentrated in urine thus reducing systemic side effects, both drugs can have their own set of side effects such as gastrointestinal upset or skin rash. Importantly, nitrofurantoin has very little impact on gut flora compared to Bactrim which can result in less risk for secondary yeast infection or diarrhea caused by an overgrowth of resistant bacteria.
What conditions is Nitrofurantoin approved to treat?
Nitrofurantoin is approved for the treatment of various bacterial infections, including:
- Uncomplicated urinary tract infections (UTIs), caused by Escherichia coli or Staphylococcus saprophyticus
- Prevention of recurrent UTIs (in patients with a history of frequent UTIs)
- Treatment and prevention of UTIs in pregnant women, as it's generally considered safe during pregnancy.
How does Nitrofurantoin help with these illnesses?
Nitrofurantoin aids in treating urinary tract infections by damaging bacterial DNA, thus inhibiting the bacteria’s ability to grow and multiply. It behaves this way by generating reactive chemicals within the bacteria which subsequently harm their genetic material. Bacteria require intact DNA for survival and replication. Nitrofurantoin's effect on bacterial DNA disrupts these essential processes, leading to bacterial death or growth suppression.
Bactrim on the other hand is a combination of two antibiotics: sulfamethoxazole and trimethoprim. These drugs work synergistically -- that is, they enhance each other's effectiveness against a wider range of bacteria than either drug alone could tackle. Sulfamethoxazole interferes with the production of folic acid in bacteria – an essential nutrient necessary for making proteins and DNA – whereas trimethoprim blocks a different step in folic acid synthesis.
In essence, both Nitrofurantoin and Bactrim are potent antibacterial agents but they combat infections through distinct mechanisms; Nitrofurantoin directly damages bacterial DNA while Bactrim interrupts crucial metabolic pathways.
What is Bactrim?
Bactrim is a brand name for the combination of two antibiotics: sulfamethoxazole and trimethoprim. It works by inhibiting the production of folic acid in bacteria, which is essential to their survival. This dual-action approach helps prevent resistance and increase effectiveness against a variety of bacterial infections. Bactrim was first approved by the FDA in 1973.
As Bactrim does not act on human cells (which do not produce folic acid), its side effect profile can be significantly different from other antibiotic classes like nitrofurantoin that can affect healthy cells as well as those causing an infection. Specifically, Bactrim tends to cause fewer gastrointestinal issues and instances of peripheral neuropathy than nitrofurantoin—a common choice for treating urinary tract infections—which may make it more suitable for patients who have experienced these side effects with other antibiotics.
However, due to its broad-spectrum nature, it's important to only use Bactrim when necessary to prevent development of resistant strains. The combined action on multiple pathways involved in bacterial growth makes it especially effective against various types of infections where typical antibiotics might fail.
What conditions is Bactrim approved to treat?
Bactrim is a potent antibiotic, approved for the treatment of various infections such as:
- Urinary tract infections (UTIs)
- Bronchitis caused by specific bacteria
- Ear infections (otitis media)
- Shigellosis and certain types of diarrhea
- Pneumonia induced by Pneumocystis jirovecii
How does Bactrim help with these illnesses?
Bactrim, also known as trimethoprim-sulfamethoxazole, is an antibiotic combination that works by inhibiting two consecutive steps in the biosynthesis of nucleic acids and proteins essential to many bacteria. It affects bacterial replication and function, thereby treating various types of infections. This broad spectrum antibiotic covers more strains compared to nitrofurantoin which primarily targets urinary tract pathogens. Bactrim's dual action on both folate synthesis and utilization not only makes it highly effective but also widens its scope beyond UTIs (like with Nitrofurantoin) to include other systemic bacterial infections such as bronchitis, otitis media or pneumonia. These properties often make Bactrim a preferred choice when addressing a wider range or unknown type of infection compared to specific antibiotics like Nitrofurantoin.
How effective are both Nitrofurantoin and Bactrim?
Both Nitrofurantoin and Bactrim (trimethoprim/sulfamethoxazole) are effective antibiotics commonly used for treating urinary tract infections (UTIs), and both have been on the market for many years, with Bactrim gaining FDA approval in 1973, followed by Nitrofurantoin in 1953. Their mechanisms of action differ; nitrofurantoin damages bacterial DNA while trimethoprim and sulfamethoxazole inhibit bacterial growth by preventing synthesis of essential proteins.
Randomized controlled trials comparing these two medications generally show similar efficacy rates in curing UTIs. However, a study published in The Journal of Antimicrobial Chemotherapy found that patients treated with nitrofurantoin were less likely to need retreatment within one month compared to those treated with trimethoprim-sulfamethoxazole. This might suggest that nitrofurantoin is somewhat more effective at eradicating bacteria from the urinary tract.
Nitrofurantoin's side effect profile has been well-studied due to its long history of use, however it should be avoided or used cautiously among individuals with impaired kidney function as this can increase risk for toxicity – particularly pulmonary toxicity. On the other hand, Bactrim carries risks including rash and hypersensitivity reactions, which may be severe.
A 2016 review published in Current Drug Safety concluded that nitrofurantoin appears safer than alternatives like fluoroquinolones (e.g., ciprofloxacin) due to lower risk for Clostridioides difficile infection following treatment. Conversely, there is ongoing debate about whether resistance patterns support preferential prescribing of either medication over the other when treating uncomplicated UTI’s. Nonetheless both remain first-line options depending on local resistance patterns.
Related trials for nitrofurantoin and bactrim
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Nitrofurantoin typically prescribed?
Oral dosages of Nitrofurantoin range from 50-100 mg taken four times daily. For most urinary tract infections, a lower dose of 50 mg is usually effective. However, for more severe cases or persistent infections, the dosage may be increased to 100 mg four times daily. Children can also take Nitrofurantoin but the dose will depend on their weight and should be determined by a healthcare professional. After a few weeks if there's no response, your doctor might consider increasing the dosage or switching medication entirely. The maximum dosage that should not be exceeded in any case is 600mg/day.
At what dose is Bactrim typically prescribed?
Bactrim treatment typically begins with a dosage of 160/800 mg (sulfamethoxazole/trimethoprim) twice daily. The dose can then be adjusted based on the severity of the infection, and it's usually taken every 12 hours. The maximum dose for severe infections is two tablets every 12 hours, which may be increased if there is no response to initial treatment after a few days. Always remember that Bactrim should be taken with plenty of fluids to prevent kidney stones and it should be used under medical supervision due to its potential interaction with other drugs and side effects.
What are the most common side effects for Nitrofurantoin?
Common side effects of Nitrofurantoin include:
- Nausea, vomiting
- Appetite loss (anorexia)
- Headache
- Dizziness and drowsiness
- Abdominal pain
- Diarrhea
- Mild rash or itching
While Bactrim may cause some similar side effects such as nausea, vomiting, and rash, it can also lead to:
- Insomnia
- Weakness (asthenia)
- Serious skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis -A potential decrease in platelets which could result in easy bruising or bleeding
Both medications have their own risks and benefits. It's important to discuss all your health conditions with your healthcare provider before starting any new medication.
Are there any potential serious side effects for Nitrofurantoin?
While Nitrofurantoin and Bactrim are both antibiotics used to treat urinary tract infections, they can have different side effects. In rare cases, Nitrofurantoin may cause:
- Signs of lung problems such as chest pain, chills or fever
- Changes in the amount or color of your urine
- Unusual fatigue or weakness
- Numbness or tingling in your hands and feet
- Symptoms of liver problems like yellowing eyes/skin, persistent nausea/vomiting
On the other hand, Bactrim might lead to serious conditions such as:
- Allergic reactions characterized by itching/swelling (especially of the face/tongue/throat)
- Severe dizziness
- Trouble breathing
- Symptoms suggestive of a severe intestinal condition due to a bacteria called C. difficile -Persistent diarrhea that doesn't improve and stomach/abdominal pain.
These lists do not include all possible side effects for either drug; if you notice any changes during treatment with either medication, it's important to consult with a healthcare provider immediately.
What are the most common side effects for Bactrim?
Bactrim, an antibiotic often prescribed for bacterial infections, can have various side effects. Some of the most common ones include:
- Nausea and vomiting
- Loss of appetite
- Mild skin rash or itching
- Possible dizziness or headache
- Increased sensitivity to sunlight leading to sunburns easily
Less common but more serious side effects may include:
- Severe stomach pain
- Persistent diarrhea with blood/mucus
- Sudden severe allergies manifesting as hives, difficulty breathing, swelling around lips/tongue/face/throat.
It's crucial that if these severe symptoms occur during your treatment with Bactrim, you seek immediate medical attention. Likewise, ensure you are not allergic to sulfa drugs before starting a regimen with Bactrim as it is a sulfonamide-based medication.
Are there any potential serious side effects for Bactrim?
Bactrim, while being an effective treatment for a range of bacterial infections, can occasionally lead to serious side effects including:
- Signs of an allergic reaction: hives; difficulty breathing; swelling in your face or throat
- Serious skin reactions: fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling
- A severe intestinal condition due to a resistant bacteria (Clostridium difficile-associated diarrhea): persistent diarrhea that does not improve or worsens
- Severe liver problems manifesting as loss of appetite, stomach pain (especially on the upper right part), dark urine coloration and yellowing eyes/skin (jaundice)
- Unusual bleeding/bruising due to low platelets level in blood
- Severe kidney problems which may include painful/confrequent urination and lower backache.
If you experience any such symptoms when taking Bactrim it is important that you seek immediate medical attention.
Contraindications for Nitrofurantoin and Bactrim?
Both Nitrofurantoin and Bactrim, as with most other antibiotic medications, may cause adverse reactions in some individuals. If you notice symptoms such as persistent nausea or vomiting, severe stomach or abdominal pain, yellowing eyes or skin, dark urine or unusual tiredness after taking these drugs, please seek immediate medical attention.
Neither Nitrofurantoin nor Bactrim should be taken if you are currently taking certain medications that interact negatively with them. For instance, for Nitrofurantoin this includes probenecid and sulfinpyrazone; for Bactrim it includes dofetilide and methenamine. Always inform your physician about all the medications you are taking: this allows a safe period to clear out any potential drug interactions.
In addition to medication interactions, both drugs have specific health conditions they might exacerbate. These include kidney disease (for Nitrofurantoin) and blood disorders (for Bactrim). Therefore always disclose your entire medical history to your doctor before starting these antibiotics.
How much do Nitrofurantoin and Bactrim cost?
For the brand name versions of these drugs:
- The price for 30 capsules of Macrodantin (a brand name version of Nitrofurantoin 50 mg) is about $130, which works out to approximately $4.30/day.
- A pack of Bactrim DS (double strength), containing 20 tablets, averages around $40 or so, thus working out to roughly $2/day if you are using one tablet per day.
Therefore, in terms of cost alone and assuming standard dosages based on common prescriptions, Bactrim tends to be less expensive than Macrodantin on a per-day treatment basis. However, it's important to stress that cost should not be your only consideration when selecting between these two medications.
Looking at their generic counterparts:
- Generic nitrofurantoin can be found for as little as about $0.60/day depending on dose and location.
- Generic sulfamethoxazole/trimethoprim (the active ingredients in Bactrim) usually costs less than this but prices can vary widely from place to place – from as low as about $0.25 up to more than a dollar per day also largely dependent upon dosage and location where purchased.
Popularity of Nitrofurantoin and Bactrim
Nitrofurantoin, both in generic form and under brand names like Macrobid or Macrodantin, was estimated to have been prescribed to about 2.8 million people in the US in 2020. Nitrofurantoin accounted for nearly 15% of urinary tract infection (UTI) prescriptions within the same year. It has been a staple antibiotic used against UTIs since its FDA approval back in the early fifties.
Trimethoprim/sulfamethoxazole, more commonly known by its branded version Bactrim, was prescribed to approximately 3 million individuals throughout America during 2020. In terms of UTI treatments, it accounted for just below 20% of overall prescriptions given out that year. Its popularity as an antimicrobial treatment has remained fairly stable over recent years with no significant increase or decrease observed over the last decade.
Conclusion
Both Nitrofurantoin and Bactrim (trimethoprim-sulfamethoxazole) are frequently used in the treatment of urinary tract infections (UTIs). They have long-standing records of effectiveness, backed by numerous clinical studies indicating that they are more effective than placebo treatments. Both drugs work differently: Nitrofurantoin damages bacterial DNA, while Bactrim inhibits folic acid synthesis crucial for bacterial growth.
Nitrofurantoin is often considered a first-line treatment option for uncomplicated UTIs due to its low resistance rates. However, it should not be used if kidney function is severely impaired or near term in pregnancy due to potential risks to the fetus.
Bactrim would usually be considered as an alternative treatment or in cases where there's resistance to nitrofurantoin. It can also treat other types of infections beyond UTIs but should not be taken by people with significant liver disease or those who have had previous allergic reactions to sulfa medications.
Both drugs come in generic forms providing cost savings especially for patients paying out-of-pocket. The side effect profiles include nausea, vomiting, rash and hypersensitivity reactions with both drugs being generally well-tolerated. For both drugs, patients must closely monitor their symptoms when starting treatment and seek medical help immediately if they notice any worsening conditions or unusual side effects.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Cunha, B. A. (1988, July). Nitrofurantoin—current concepts. Urology. Elsevier BV.http://doi.org/10.1016/0090-4295(88)90460-8
- McOsker, C. C., & Fitzpatrick, P. M. (1994, May 1). Nitrofurantoin: Mechanism of action and implications for resistance development in common uropathogens. Journal of Antimicrobial Chemotherapy. Oxford University Press (OUP).http://doi.org/10.1093/jac/33.suppl_a.23
- Geddes, A. M., Ball, A. P., & Farrell, I. D. (1979, November 1). Co-trimoxazole for the treatment of serious infections. Journal of Antimicrobial Chemotherapy. Oxford University Press (OUP).http://doi.org/10.1093/jac/5.supplement_b.221
- Munoz-Davila, M. (2014, February 10). Role of Old Antibiotics in the Era of Antibiotic Resistance. Highlighted Nitrofurantoin for the Treatment of Lower Urinary Tract Infections. Antibiotics. MDPI AG.http://doi.org/10.3390/antibiotics3010039
- Wang, A., Nizran, P., Malone, M. A., & Riley, T. (2013, September). Urinary Tract Infections. Primary Care: Clinics in Office Practice. Elsevier BV.http://doi.org/10.1016/j.pop.2013.06.005
- Koch-Weser, J., Rubin, R. H., & Swartz, M. N. (1980, August 21). Trimethoprim-Sulfamethoxazole. New England Journal of Medicine. Massachusetts Medical Society.http://doi.org/10.1056/nejm198008213030804
- Kashanian, J., Hakimian, P., Blute, M., Jr, Wong, J., Khanna, H., Wise, G., & Shabsigh, R. (2008, November 21). Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU International. Wiley.http://doi.org/10.1111/j.1464-410x.2008.07809.x
- ten Doesschate, T., Hendriks, K., van Werkhoven, C. H., van der Hout, E. C., Platteel, T. N., Groenewegen, I. A. M., … Geerlings, S. E. (2022, February). Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study. Clinical Microbiology and Infection. Elsevier BV.http://doi.org/10.1016/j.cmi.2021.05.048
- Stuhec, M. (2014, March). Trimethoprim-sulfamethoxazole-related hallucinations. General Hospital Psychiatry. Elsevier BV.http://doi.org/10.1016/j.genhosppsych.2013.10.016
- Chudnofsky, C. R., & Otten, E. J. (1989, January). Acute pulmonary toxicity to nitrofurantoin. The Journal of Emergency Medicine. Elsevier BV.http://doi.org/10.1016/0736-4679(89)90403-4
- Traub, W. H., & Fukushima, P. I. (1979). Nonspecific Resistance of <i>Serratia marcescens</i> Against Antimicrobial Drugs. Chemotherapy. S. Karger AG.http://doi.org/10.1159/000237840